Filing Details
- Accession Number:
- 0000880771-17-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-24 19:01:29
- Reporting Period:
- 2017-01-20
- Filing Date:
- 2017-01-24
- Accepted Time:
- 2017-01-24 19:01:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 880771 | Sciclone Pharmaceuticals Inc | SCLN | Pharmaceutical Preparations (2834) | 943116852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363213 | Friedhelm Blobel | 950 Tower Lane, Suite 900 Foster City CA 94404 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-20 | 12,400 | $1.81 | 99,184 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-20 | 12,400 | $10.38 | 86,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-01-23 | 18,000 | $1.81 | 104,784 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-23 | 18,000 | $10.41 | 86,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-01-23 | 4,807 | $1.08 | 91,591 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-23 | 4,807 | $10.41 | 86,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-01-24 | 21,132 | $1.08 | 107,916 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-24 | 21,132 | $10.51 | 86,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-01-24 | 4,793 | $1.08 | 91,577 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-24 | 4,793 | $10.41 | 86,784 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2017-01-20 | 12,400 | $0.00 | 12,400 | $1.81 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2017-01-23 | 18,000 | $0.00 | 18,000 | $1.81 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2017-01-23 | 4,807 | $0.00 | 4,807 | $1.08 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2017-01-24 | 21,132 | $0.00 | 21,132 | $1.08 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2017-01-24 | 4,793 | $0.00 | 4,793 | $1.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,000 | 2018-03-18 | No | 4 | M | Direct | |
| 0 | 2018-03-18 | No | 4 | M | Direct | |
| 95,193 | 2019-03-06 | No | 4 | M | Direct | |
| 74,061 | 2019-03-06 | No | 4 | M | Direct | |
| 69,268 | 2019-03-06 | No | 4 | M | Direct |
Footnotes
- The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2016.
- Granted under the Issuer's 2005 Equity Incentive Plan.
- 1/36th of such shares will vest on June 1, 2010 and 1/36th will vest monthly thereafter over a three-year period, provided the reporting person remains employed by the Company.
- 25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
Billionaire Hedge Funds
